Literature DB >> 2966018

The effect of hypertension and left ventricular hypertrophy on the lower range of coronary autoregulation.

D G Harrison1, M S Florentine, L A Brooks, S M Cooper, M L Marcus.   

Abstract

These studies were performed to test the hypothesis that left ventricular hypertrophy arising as a complication of chronic hypertension is associated with impaired coronary autoregulation. Twelve dogs with hypertension and left ventricular hypertrophy (one-kidney, one-clip model) and 11 normal dogs were instrumented and subsequently studied while conscious. Circumflex pressure, measured with an intracoronary catheter, was adjusted to 100, 75, and 40 mm Hg with a hydraulic occluder that was placed proximally. At each circumflex pressure, myocardial perfusion was measured with radioactive microspheres. Reduction of circumflex pressure over this range did not significantly alter heart rate, left atrial pressure, or arterial pressure. In normal dogs, reduction of circumflex pressure did not alter total myocardial perfusion or the transmural distribution of perfusion. In contrast, in dogs with hypertension and left ventricular hypertrophy, circumflex subendocardial perfusion decreased 46% when pressure was decreased from 100 to 40 mm Hg (p less than .05 compared with normal). Autoregulation was quantified for each third of myocardium with the use of autoregulatory gain values (1 = perfect autoregulation; 0 = the absence of autoregulation). For pressure changes of 100 to 75 mmHg, values for autoregulatory gain were near unity for all layers of myocardium in both groups of animals. When pressure was decreased from 75 to 40 mm Hg, values for autoregulatory gain among the normal and hypertensive groups were, respectively: for subepicardium 1 +/- 0.2 (mean +/- SE) vs 0.9 +/- 0.2 (p = NS), for the midwall 0.8 +/- 0.2 vs 0.5 +/- 0.2 (p = NS), and for the subendocardium 0.8 +/- 0.1 vs 0.1 +/- 0.2 (p less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 2966018     DOI: 10.1161/01.cir.77.5.1108

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

1.  Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension.

Authors:  Martin Rodriguez-Porcel; Xiang-Yang Zhu; Alejandro R Chade; Beatriz Amores-Arriaga; Noel M Caplice; Erik L Ritman; Amir Lerman; Lilach O Lerman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-07       Impact factor: 4.733

2.  Current status of aggressive blood pressure control.

Authors:  Steven G Chrysant
Journal:  World J Cardiol       Date:  2011-03-26

Review 3.  Noninvasive 24 hour ambulatory blood pressure monitoring: current status.

Authors:  A Stanton; E O'Brien
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

4.  Aerobic exercise reduces oxidative stress and improves vascular changes of small mesenteric and coronary arteries in hypertension.

Authors:  Fernanda R Roque; Ana M Briones; Ana B García-Redondo; María Galán; Sonia Martínez-Revelles; Maria S Avendaño; Victoria Cachofeiro; Tiago Fernandes; Dalton V Vassallo; Edilamar M Oliveira; Mercedes Salaices
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

5.  Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control.

Authors:  John W McEvoy; Yuan Chen; Andreea Rawlings; Ron C Hoogeveen; Christie M Ballantyne; Roger S Blumenthal; Josef Coresh; Elizabeth Selvin
Journal:  J Am Coll Cardiol       Date:  2016-08-30       Impact factor: 24.094

6.  Mechanisms of regional ischaemic changes during dipyridamole echocardiography in patients with severe aortic valve stenosis and normal coronary arteries.

Authors:  M Baroni; S Maffei; M Terrazzi; C Palmieri; F Paoli; A Biagini
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

7.  Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy.

Authors:  S D Pringle; F G Dunn; A C Tweddel; W Martin; P W Macfarlane; J H McKillop; A R Lorimer; S M Cobbe
Journal:  Br Heart J       Date:  1992-05

Review 8.  Does a reduction in left ventricular hypertrophy reduce cardiovascular morbidity and mortality?

Authors:  F H Messerli; F Soria
Journal:  Drugs       Date:  1992       Impact factor: 9.546

9.  Complete reversibility of physiological coronary vascular abnormalities in hypertrophied hearts produced by pressure overload in the rat.

Authors:  S Isoyama; N Ito; M Kuroha; T Takishima
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

10.  Association of optimal blood pressure with mortality in patients taking antihypertensive medications.

Authors:  Dong-Ho Yun; Hye-Sun Lee; Won-Jun Choi; Hyuk-Jae Chang; Da-Hye Son; Ji-Won Lee
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-20       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.